1: Cariou B, et al.. Association between plasma PCSK9 and gamma-glutamyl transferase levels in diabetic patients. Atherosclerosis. 2010 Apr 20. [Epub ahead of print]

2: Marian AJ. PCSK9 as a therapeutic target in atherosclerosis. Curr Atheroscler Rep. 2010 May;12(3):151-4.

3: Palmer-Smith H, Basak A. Regulatory Effects of Peptides from the Pro and Catalytic Domains of Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) on Low-Density Lipoprotein Receptor (LDL-R). Curr Med Chem. 2010 Apr 28. [Epub ahead of print]

4: Huang CC, et al.. Longitudinal association of PCSK9 sequence variations with low-density lipoprotein cholesterol levels: the Coronary Artery Risk Development in Young Adults Study. Circ Cardiovasc Genet. 2009 Aug;2(4):354-61. Epub 2009 Jun 10.